Virtu Financial LLC - ADAPTIMMUNE THERAPEUTICS PLC ownership

ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 68 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q4 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.

Quarter-by-quarter ownership
Virtu Financial LLC ownership history of ADAPTIMMUNE THERAPEUTICS PLC
ValueSharesWeighting
Q1 2023$96
+118.2%
88,234
+193.1%
0.01%
+66.7%
Q4 2022$44
-99.9%
30,103
-25.7%
0.01%
+50.0%
Q3 2022$44,000
+51.7%
40,503
+133.7%
0.00%
+100.0%
Q2 2022$29,000
-42.0%
17,328
-29.2%
0.00%
-50.0%
Q1 2022$50,000
-79.7%
24,470
-48.5%
0.00%
-81.8%
Q3 2021$246,000
+23.6%
47,542
+139.6%
0.02%
-4.3%
Q2 2020$199,000
-50.7%
19,845
-67.2%
0.02%
+9.5%
Q4 2017$404,000
+75.7%
60,473
+115.6%
0.02%
+90.9%
Q3 2017$230,00028,0510.01%
Other shareholders
ADAPTIMMUNE THERAPEUTICS PLC shareholders Q4 2022
NameSharesValueWeighting ↓
NEA Management Company, LLC 15,832,611$68,080,0003.54%
Matrix Capital Management Company, LP 28,000,000$120,400,0003.21%
Virtus ETF Advisers LLC 50,655$218,0000.46%
TFG Asset Management GP Ltd 500,000$2,150,0000.27%
Rock Springs Capital Management LP 800,000$3,440,0000.13%
Orbimed Advisors 1,350,655$5,808,0000.09%
Vident Investment Advisory, LLC 289,340$1,244,0000.07%
WS MANAGEMENT LLLP 185,537$798,0000.05%
Rathbones Group PLC 285,722$1,229,0000.04%
Tekla Capital Management LLC 228,496$983,0000.04%
View complete list of ADAPTIMMUNE THERAPEUTICS PLC shareholders